Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into ...
In clinical communication, it is believed that accurately understanding and appropriately responding to patients’ emotions contributes to treatment effectiveness and patient satisfaction. Recently, ...
While AI coding assistants dramatically lower the barrier to building software, the true shift lies in the move toward "disposable code", ...
Abstract: Accurate estimation of contact forces acting on robotic manipulators is essential for safe and high-performance physical interaction. However, classical disturbance Kalman filter approaches ...